Skip to content

Nuvalent, Inc. NUVL Change in Other Assets

Change in Other Assets at other companies

Pfizer logo
PfizerPFE
-$322.25M+61.9%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$1.05M+1,152%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$1.03M-27.7%
Exelixis logo
ExelixisEXEL
-$58.65M-189%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$10.47M+1,469%
Incyte logo
IncyteINCY
-$9.19M-115%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s change in other assets?
Nuvalent, Inc. (NUVL) reported change in other assets of $3K in Q1 2026.
How has Nuvalent, Inc.'s change in other assets changed year-over-year?
Nuvalent, Inc.'s change in other assets increased by 100.4% year-over-year, from -$818K to $3K.
What is the long-term trend for Nuvalent, Inc.'s change in other assets?
Over 2 years (2022 to 2025), Nuvalent, Inc.'s change in other assets has grown at a 106.2% compound annual growth rate (CAGR), from $1.49M to $6.34M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.